Beijing Tiantan Biological Products Corporation LimitedSSE: 600161

2025 Semi-annual Report

Aug 22, 2025 · Issued by Beijing Tiantan Biological Products Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Aug 22, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-72

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Beijing Tiantan Biological Products Corporation Limited on 6ix

Earlier from Beijing Tiantan Biological Products

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Aug 21, 2025
Brief Announcement on Semi-annual Earnings for 2025Aug 7, 2025
Announcement on Waiving the Acquisition Opportunity of PLBIOAug 5, 2025
Announcement on Subsidiary Obtaining Notice of Approval for Drug Supplementary ApplicationJul 24, 2025
Announcement on Resolutions of the 22nd Meeting of the 9th Board of DirectorsJul 1, 2025

Later from Beijing Tiantan Biological Products

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseAug 29, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingSep 9, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025Sep 19, 2025
Announcement on Subsidiary Obtaining Drug GMP Compliance Inspection NoticeSep 23, 2025
Announcement on Resolutions of the 25th Meeting of the 9th Board of DirectorsSep 27, 2025

All Beijing Tiantan Biological Products news releases

Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.

Follow Beijing Tiantan Biological Products